FFCP PHASE2:Hg19::chr4:186598476..186598485,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p@chr4:186598476..186598485, + |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chr4:186598476..186598485, + |
| Coexpression cluster: | C56_heart_left_umbilical_skeletal_penis_diaphragm_tongue |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p@chr4:186598476..186598485+ |
|---|
0.0
0.5
1.0
1.5
2.0
2.5
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| heart left ventricle | 9.91e-41 | 1 |
| cardiac ventricle | 9.91e-41 | 1 |
| future cardiac ventricle | 9.91e-41 | 1 |
| primary circulatory organ | 4.16e-24 | 27 |
| cardiac chamber | 1.40e-14 | 3 |
| compound organ | 5.09e-10 | 68 |
| heart | 1.15e-07 | 24 |
| primitive heart tube | 1.15e-07 | 24 |
| primary heart field | 1.15e-07 | 24 |
| anterior lateral plate mesoderm | 1.15e-07 | 24 |
Showing 1 to 10 of 15 entries
| Ontology term | p-value | n |
|---|---|---|
| heart disease | 5.22e-79 | 2 |
| vascular disease | 2.21e-40 | 1 |
| ischemia | 2.21e-40 | 1 |
| extrinsic cardiomyopathy | 2.21e-40 | 1 |
| myocardial ischemia | 2.21e-40 | 1 |
| myocardial infarction | 2.21e-40 | 1 |
| cardiovascular system disease | 3.31e-40 | 4 |
Showing 1 to 7 of 7 entries
